Search for: "Pfizer, IncĀ " Results 1281 - 1300 of 1,505
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Jul 2008, 10:10 pm
He had been living a secret and sordid life on the Internet, trading sexually explicit images of young children, many of them engaged in sadistic or masochistic acts.The former director of global patents at Pfizer Inc., who has been held without bond since he was arrested in March, pleaded guilty in U.S. [read post]
25 Jul 2008, 10:51 am
Pfizer and the other defendants in the Mirapex litigation are seeking a bifurcated trial plan. [read post]
22 Jul 2008, 3:10 pm
It resulted in 13 major and 10 minor malformations in combination with other epilepsy therapies including Sanofi-Aventis' Frisium, Sabril, Epilim or Depakine, Pfizer Inc.'s Zarontin, UCB SA's Keppra as well as generic drugs carbamazepine, phenobarbitral or phenytoin. [read post]
18 Jul 2008, 8:34 am
: (Patent Circle), Tanzania to conduct study on impact of counterfeit medicines: (Afro-IP), US: New rules on generic biological medicines under US Congressional debate: (Intellectual Property Watch), Pharma & Biotech - Products Acular (Ketorolac) – US: CAFC rules against Apotex reverse doctrine of equivalents: Roche Palo Alto & Allergan, Inc v Apotex: (Patent Circle), Carbatrol (Carbamazapine) – US: Federal judge allows Corepharma to seek DJ that its… [read post]
11 Jul 2008, 4:30 am
Here is IP Think Tank’s weekly selection of top intellectual property news breaking in the blogosphere and internet. [read post]
8 Jul 2008, 1:00 pm
Some of the tops selling epilepsy medication that can be affected by the warning are GlaxoSmithKline Plc's Lamictal,  Pfizer Inc's Lyrica, Johnson & Johnson's Topamax and Abbott Laboratories Inc's Depakote. [read post]
7 Jul 2008, 2:53 pm
On November 18, 2004, Pfizer, Inc., the manufacturer of Depo-Provera, a contraceptive injection, issued a warning to Health Care Professionals that "women who use Depo-Provera Contraceptive Injection may lose significant bone mineral density. [read post]
5 Jul 2008, 11:05 am
: (IP tango), China: Pfizer loses trade mark action against Jaingsu Lianhuan Pharmaceutical Co over 3D mark: (Rouse & Co International), India: More patents for new forms issued to generics: (Patent Circle), India: Gauri Kamath on drug ‘differential pricing’ in India: (Spicy IP), Mexico: Revised health supplies regulations promise changes for generics: (International Law Office), US: World drug pricing crisis: Congressmen criticise US Trade Representative over… [read post]
27 Jun 2008, 10:04 am
: (The Invent Blog), Impressive work on history of ‘Happy Birthday’ and copyright protection: (Innovationpartners), Gender and copyright: (Patry Copyright Blog)   Events 1 July: US PLI: ‘Prior art & obviousness 2008: The PTO and CAFC perspective on patent law sections 102 & 103’ - New York: (Patent Docs), 1-2 July – C5 conference on intellectual asset management for high-tech industries – Paris: (c5-online.com), 2… [read post]
24 Jun 2008, 12:06 pm
Further to the demise of Pfizer's chief patent person, Alan Hesketh, over child pornography, the pharma log blog has some other items in a post, Rumors, innuendo, criminal charges and changes inside Pfizer Inc's legal department, which has some suggestions about a link to the Spitzer/prostitution thing.IPBiz was more interested in the blog's mention of "superlawyer" Amy Schulman, otherwise mentioned in a WSJ:If Amy Schulman's schedule as a… [read post]
20 Jun 2008, 1:53 pm
District Court in Boston and New York state court held joint hearings on whether lawsuits against Pfizer, Inc. based on Neurontin could continue. [read post]
20 Jun 2008, 8:07 am
: (IP finance), Technical assistance a key point of discussion at TRIPS Council: (Intellectual Property Watch), WIPO turmoil as new DG’s future comes under threat: (IAM), WIPO to host inter-regional forum to explore strategies to enhance development and service-orientation of IP offices: (WIPO), Controversy over lack of transparency and overreaching enforcement provisions in ACTA: (Spicy IP), (Spicy IP)   Global - Trade Marks / Domain Names / Brands World anti-counterfeiting day:… [read post]
19 Jun 2008, 10:58 pm
" Manufactured by Pfizer, Inc., Chantix, ahs seizures, dizziness, heart irregularity, diabetes and more than 100 accidents. [read post]
18 Jun 2008, 1:48 pm
Pfizer's legal department has had its share of changes and turmoil over the last few months.First Alan Hesketh, Pfizer Inc.'s vice president and global head of patents was charged with child pornography.A month later, Pfizer's general counsel, and Kindler-confidant, Alan Waxman, resigned for "personal reasons. [read post]
18 Jun 2008, 12:41 pm
The Lipitor Scorecard has been updated, so go and have a look at the latest results - across 23 countries.For those keen on a little pharmaceutical patent blood sport, don't despair, the battle wages on in five European counries: Finland, Spain, Portugal, Denmark and RomaniaHere's the press release from Pfizer: Pfizer and Ranbaxy Settle Lipitor Patent Litigation (mostly) Worldwide Ranbaxy to Receive License in U.S. on November 30, 2011; NEW YORK--(BUSINESS… [read post]
18 Jun 2008, 4:39 am
AP reports: Pfizer Inc. and India's Ranbaxy Laboratories Ltd. said June 18 they have settled their patent dispute over the blockbuster cholesterol drug Lipitor, delaying the release of generic versions in the U.S. until Nov. 30, 2011.Forbes gave a more complete account of the event, and noted an immediate drop in Ranbaxy stock of 5%:Under the terms of the agreement, Ranbaxy will have a license to sell generic versions of Lipitor and Caduet in the United States, as of Nov.… [read post]
11 Jun 2008, 8:11 pm
Today Pfizer Inc's stock price hits rock bottom $17.55Unbelievable. [read post]
5 Jun 2008, 6:29 pm
Kindler's secret plan for Pfizer is not to get the stock up . . . that's virtually impossible, and he knows it.Solution: Drive the stock down to below $14, enough to get the sharks circling, then accept a take-over offer for $22, and cash in all executive management parachutes.You heard it here first.By accessing this site, you are agreeing to comply with and be bound by the terms of use agreement and privacy policy. [read post]